Is my “resistant hypertensive” patient a candidate for techniques targeting the sympathetic nervous system?


4 presentations from the RHC AP 2013, slides from the third session are available now!

 On these 4 case-based presentations you can learn

- which patients may be considered as optimal candidates for renal sympathetic denervation

Screen for secondary causes

Patient 1: A long-term success patient after renal denervation


Screen for secondary causes

Patient 2: A non-responding patient

T. Zeller (GERMANY)

Screen for secondary causes

Patient 3: What about a patient with metabolic syndrome and/or sleep apnea syndrome?


Screen for secondary causes


Patient 4: A diabetic patient

R. Schmieder (GERMANY)


 Chrsitian UKENA answers the following questions

 - Where do you see indications for renal denervation in arrhythmic disorders?

- Could you share a specific exemple of renal denervation performed in an arrhythmia case?

- What can a participant expect to learn during the Resistant Hypertension Course 2014?

The Concluding Remarks from the Chairmen of the Resistant Hypertension Course Asia Pacific 2013

 Arterial hypertension is the single largest contributor to death worldwide. One in three adults (around 1 billion people) worldwide are affected and the number is expected to increase to 1.6 billion by 2025. Data from the World Health Organization (WHO) Southeast Asian regions indicate that the prevalence of hypertension (blood pressure ≥ 140/90mmHg) ranging from 5% to 47% in men and 7% to 38% in women causing up to 66% of cardiovascular diseases, including fatal ischemic heart disease and stroke. This finding underlines the vast impact that blood pressure-lowering strategies could have in this populous region.

More Slides of the first and second day →  


Featured Image